Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.
- 1 February 2010
- journal article
- research article
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 78 (1) , 55-61
Abstract
Depressive symptoms are associated with poor smoking cessation outcomes, and there remains continued interest in behavioral interventions that simultaneously target smoking and depressive symptomatology. In this pilot study, we examined whether a behavioral activation treatment for smoking (BATS) can enhance cessation outcomes. A sample of 68 adult smokers with mildly elevated depressive symptoms (M = 43.8 years of age; 48.5% were women; 72.7% were African American) seeking smoking cessation treatment were randomized to receive either BATS paired with standard treatment (ST) smoking cessation strategies including nicotine replacement therapy (n = 35) or ST alone including nicotine replacement therapy (n = 33). BATS and ST were matched for contact time and included 8 sessions of group-based treatment. Quit date was assigned to occur at Session 4 for each treatment condition. Participants completed a baseline assessment; furthermore, measures of smoking cessation outcomes (7-day verified point-prevalence abstinence), depressive symptoms (Beck Depression Inventory-II; Beck, Steer, & Brown, 1996), and enjoyment from daily activities (Environmental Reward Observation Scale; Armento & Hopko, 2007) were obtained at 1, 4, 16, and 26 weeks post assigned quit date. Across the follow-ups over 26 weeks, participants in BATS reported greater smoking abstinence (adjusted odds ratio = 3.59, 95% CI [1.22, 10.53], p = .02) than did those in ST. Participants in BATS also reported a greater reduction in depressive symptoms (B = -1.99, SE = 0.86, p = .02) than did those in ST. Results suggest BATS is a promising intervention that may promote smoking cessation and improve depressive symptoms among underserved smokers of diverse backgrounds.Keywords
Funding Information
- National Institute on Drug Abuse (R01 DA18730, K23 DA023143)
This publication has 19 references indexed in Scilit:
- A Controlled Trial of Bupropion Added to Nicotine Patch and Behavioral Therapy for Smoking Cessation in Adults With Unipolar Depressive DisordersJournal of Clinical Psychopharmacology, 2008
- Psychological mediators of bupropion sustained‐release treatment for smoking cessationAddiction, 2008
- Dimensions of depressive symptoms and smoking cessationNicotine & Tobacco Research, 2008
- Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects.Journal of Abnormal Psychology, 2008
- Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancyBMC Public Health, 2007
- Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder.Journal of Abnormal Psychology, 2002
- A Brief Behavioral Activation Treatment for DepressionBehavior Modification, 2001
- Symptoms of depression and survival experience among three samples of smokers trying to quit.Psychology of Addictive Behaviors, 2001
- A component analysis of cognitive-behavioral treatment for depression.Journal of Consulting and Clinical Psychology, 1996
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991